Patents for A61P 1 - Drugs for disorders of the alimentary tract or the digestive system (125,798) |
---|
08/13/1998 | WO1998034918A1 Arylsulfonyl hydroxamic acid derivatives |
08/13/1998 | WO1998034615A1 Pharmaceutical composition for treatment of synaptic dysfunction comprising an oxime |
08/13/1998 | WO1998034602A2 Mediation of cytokines by melanin |
08/13/1998 | WO1998030693A3 Tumor necrosis factor receptor 5 |
08/13/1998 | CA2280228A1 Monocyclic compounds with four bifunctional residues having nk-2 antagonist action |
08/13/1998 | CA2280048A1 Il-8 receptor antagonists |
08/13/1998 | CA2279946A1 Mediation of cytokines by melanin |
08/13/1998 | CA2279575A1 Human sdf-5 protein and compositions |
08/13/1998 | CA2279531A1 Pharmaceutical composition for treatment of synaptic dysfunction comprising an oxime |
08/12/1998 | EP0857786A1 RNA dependent amidotransferase B from Staphylococcus Aureus |
08/12/1998 | EP0857785A1 RNA dependent amidotransferase C from Staphylococcus Aureus |
08/12/1998 | EP0857732A1 Human pec-60-like protein and dna encoding the same |
08/12/1998 | EP0857725A1 (N-(pyridinylmethyl)-heterocyclic)-ylideneamine compounds as nicotinic acetylcholine receptor binding agents |
08/12/1998 | EP0857485A2 Use of acemannan for the treatment of multiple sclerosis and for the correction of malabsorption |
08/12/1998 | EP0857175A1 Novel human cysteine protease |
08/12/1998 | EP0857063A1 Compositions and methods for buccal delivery of pharmaceutical agents |
08/12/1998 | EP0741687B1 Leukotriene b4 derivatives, methods of preparing them and their use as drugs |
08/12/1998 | CN1190393A Diaryldiamine derivatives and their use as delta opioid (ANT)-agonists |
08/12/1998 | CN1190346A Pharmaceutical composition comprising lactobacillus plantarum and arginine |
08/12/1998 | CN1190013A Ointment for toothache and stomatocase |
08/12/1998 | CN1190011A Medicine for gastroenteritic diseases |
08/12/1998 | CN1190005A Compound Weisukang capsule for gastropathy and its preparation |
08/11/1998 | US5792795 Treatment of inflammatory bowel disease using oral dosage forms of omega-3 polyunsaturated acids |
08/11/1998 | US5792783 Capable of modulating tyrosine kinase signal transduction in order to regulate, modulate and/or inhibit abnormal cell proliferation |
08/11/1998 | US5792772 Enatiomerically pure hydroxylated xanthine compounds |
08/11/1998 | US5792764 Pyrido-1,2,4-thiadiazine and pyrido-1,4-thiazine derivatives, their preparation and use |
08/11/1998 | US5792629 Nucleotide and amino acid sequences |
08/11/1998 | CA2076589C Naphthylethylureas and naphthylethylthioureas, the process for their preparation and pharmaceutical compositions holding same |
08/07/1998 | CA2222987A1 Novel compounds |
08/07/1998 | CA2222978A1 Novel compounds |
08/07/1998 | CA2222961A1 Novel compounds |
08/06/1998 | WO1998034121A2 Isolated p27 protein and methods for its production and use |
08/06/1998 | WO1998033890A1 Human regeneration-associated serpin-1 (rasp-1) and methods of use |
08/06/1998 | WO1998033768A1 Arylsulfonylamino hydroxamic acid derivatives |
08/06/1998 | WO1998033508A1 Calcareous material |
08/06/1998 | WO1998026768A3 Use of 7-(1-aminomethyl-2-oxa-7-aza-bicyclo[3.3.0]oct-7-yl)-quinolone carboxylic acid and naphthyridone carboxylic acid derivatives for treating helicobacter pylori infections and the gastroduodenal diseases associated therewith |
08/06/1998 | WO1998024813A3 Keratinocyte growth factors and their use in combination with glucagon-like peptide derivatives |
08/06/1998 | WO1998021332A3 Secreted proteins and polynucleotides encoding them |
08/06/1998 | CA2279594A1 Calcareous material |
08/06/1998 | CA2279459A1 Human regeneration-associated serpin-1 (rasp-1) and methods of use |
08/05/1998 | EP0856259A1 Composition for feed use comprising lyophilized live lactic bacteria |
08/05/1998 | EP0856051A1 Novel 3' terminal sequence of hepatitis c virus genome and diagnostic and therapeutic uses thereof |
08/05/1998 | EP0856050A1 Transforming growth factor alpha hi |
08/05/1998 | EP0856001A1 Pyrimidine derivatives as 5ht 2c?-receptor antagonists |
08/05/1998 | EP0690872B1 Biologically active peptides from functional domains of bactericidal/permeability-increasing protein and uses thereof |
08/05/1998 | EP0584286B1 Use of platelet derived growth factor in the preparation of a medicament for the treatment of gastrointestinal ulcers |
08/05/1998 | CN1189829A Piperazino derivatives as neurokinin antagonists |
08/05/1998 | CN1189821A Substituted oximes, hydrazones and olefins as neurokinin antagonists |
08/05/1998 | CN1189775A Use of allylamine derivatives such as terbinafine, in the manufacture of a medicament for the treatment of helicobacter pylori infection of associated diseases |
08/05/1998 | CN1189366A Gastritis pills |
08/05/1998 | CN1189362A Ulcer healing syrup |
08/05/1998 | CN1189346A Chinese medicine for treating constipation |
08/05/1998 | CN1039416C Process for preparing novel pyrido (3,2-B) (1.5) benzothiazepines |
08/04/1998 | US5789465 Collagen matrix |
08/04/1998 | US5789447 Nitric oxide releasing compounds as protective agents in ischemia reperfusion injury |
08/04/1998 | US5789426 Method for the treatment of fibroproliferative disorders by application of inhibitors of protein hydroxylation |
08/04/1998 | US5789406 Indeno 1,2-E!pyrazine-4-ones, their preparation and the medicaments containing them |
08/04/1998 | CA2149242C Quinuclidine derivative for treatment of inflammatory and gastrointestinal disorders |
08/03/1998 | CA2220852A1 Tumor necrosis related receptor, tr4 |
07/30/1998 | WO1998032753A1 THIAZOLE BENZENESULFONAMIDES AS β3 AGONISTS FOR THE TREATMENT OF DIABETES AND OBESITY |
07/30/1998 | WO1998032733A1 Sulfonyl urea derivatives and their use in the control of interleukin-1 activity |
07/30/1998 | WO1998032730A1 Aminobenzophenones as inhibitors of interleukin and tnf |
07/30/1998 | WO1998032439A1 Il-8 receptor antagonists |
07/30/1998 | WO1998032438A1 Il-8 receptor antagonists |
07/30/1998 | WO1998032428A2 Compositions comprising choline and use of choline to treat endotoxic shock |
07/30/1998 | WO1998027108A3 New amide compounds and their use as nitric oxide synthase inhibitors |
07/30/1998 | WO1998024780A3 Substituted pyrimidinone and pyridinone compounds and their use |
07/30/1998 | WO1998021237A3 Peptide compounds useful for modulating FGF receptor activity |
07/30/1998 | CA2278739A1 Thiazole benzenesulfonamides as .beta.3 agonists for the treatment of diabetes and obesity |
07/30/1998 | CA2278504A1 Il-8 receptor antagonists |
07/30/1998 | CA2278427A1 Il-8 receptor antagonists |
07/29/1998 | EP0855397A1 (r)-5-bromo-n-(1-ethyl-4-methylhexahydro-1h-1,4-diazepin-6-yl)-2-methoxy-6-methylamino-3-pyridine-carboxamide, process for producing the same and medicinal composition containing the same |
07/29/1998 | EP0855396A1 Thioctic acid metabolites and methods of use thereof |
07/29/1998 | EP0855389A2 A 3,7-dithiaprostanoic acid derivative |
07/29/1998 | EP0854711A1 gamma-RAR ANTAGONIST LIGAND OR alpha-RAR AGONIST LIGAND AS AN APOPTOSIS INHIBITOR |
07/29/1998 | EP0854710A2 USE OF A $g(g)-RAR-SPECIFIC AGONIST LIGAND TO INCREASE APOPTOSIS RATE |
07/29/1998 | EP0740668B1 Tetracyclic derivatives, process of preparation and use |
07/29/1998 | EP0717732B1 Polyamidic acid derivatives with antigastrin activity, a method for their preparation, and their pharmaceutical use |
07/29/1998 | EP0681571B1 Spiro-substituted azacycles as tachykinin receptor antagonists |
07/29/1998 | CN1188671A Electuary benefitting for liver and preparation method thereof |
07/29/1998 | CN1188657A 'Ganyankang' oral liquid-for treating hepatitis and preparation method |
07/29/1998 | CN1188655A Traditional Chinese medicine for treatment of gall stone and urinary stone |
07/28/1998 | US5786383 Pharmaceutical preparation |
07/28/1998 | US5786372 Heteroaryl compounds used as pharmaceuticals |
07/28/1998 | US5786360 Antiallergens, central nervous system stimulants, diuretics, antihistamines, cardiotonic agents; water solubility |
07/28/1998 | US5786158 Therapeutic and diagnostic methods and compositions based on notch proteins and nucleic acids |
07/28/1998 | US5785970 Method of the treatment of gastrointestinal disorders with immunogenic compositions against gastrin |
07/28/1998 | CA2105790C Nutrition for persons infected with human immunodeficiency virus |
07/28/1998 | CA2105072C Morphinan derivative and its pharmaceutical applications |
07/23/1998 | WO1998031664A1 Bis-sulfonomides hydroxamic acids as mmp inhibitors |
07/23/1998 | WO1998031379A1 tXTRACT OF FRESH REHMANNIA GLUTINOSA WHICH CAN BE USED TO STIMULATE BIFIDOBACTERIUM PROLIFERATION AND PREPARATION THEREOF |
07/23/1998 | WO1998020906A3 Treatment of diabetes with transcription factor gene |
07/22/1998 | EP0854191A2 Human cardiac/brain tolloid-like protein |
07/22/1998 | EP0853669A2 A gene associated with liver neoplastic disease |
07/22/1998 | EP0853661A1 Specific binding members for human transforming growth factor beta; materials and methods |
07/22/1998 | EP0853622A1 PROCESS FOR PREPARING 1-ARYL-4-OXOPYRROLO 3,2-c]QUINOLINE DERIVATIVES |
07/22/1998 | EP0853621A1 Novel substituted azacyclic or azabicyclic compounds |
07/22/1998 | EP0766695B1 Pyrrolidine derivatives for the treatment of cholecystokinine and gastrine-related disorders |
07/22/1998 | EP0736025B1 Dyhydrobenzofuranyl-biphenyl carboxamides having 5ht1d antagonistic activity |
07/22/1998 | EP0698014B1 3-phenylureido-1,5-benzodiazepine-diones useful as gastrin or cck antagonists |